Page 3 - Les Meilleurs doctors pour votre Radiothérapie - TOP 97 des médecins

Spécialisée en hématologie et oncologie pédiatriques – Sema Anak se concentre sur les soins du cancer chez l'enfant à l'Hôpital Universitaire Medipol Mega.

• Expert en traitements d'oncologie pédiatrique
• Travaille dans un hôpital universitaire de premier plan
• Dédicacé aux soins du cancer chez l'enfant

Le Dr Bunyamin Kaplan est un radio-oncologue dévoué à l'Hôpital universitaire Medipol Mega, se concentrant sur des traitements de radiothérapie précis et efficaces.

• Spécialisé en techniques de radiothérapie avancées
• Travaille dans un hôpital universitaire de premier plan
• Engagé envers des soins personnalisés aux patients

Professeur Agrégé depuis 2016, le Dr Ozatli est spécialisé dans les cancers du sein, du poumon et gastro-intestinaux à l'Istinye University Liv Hospital Bahcesehir.

• Spécialiste en médecine interne avec de l'expérience dans les meilleurs hôpitaux turcs
• Expérimenté dans le traitement de cas d'oncologie complexes couvrant plusieurs types de cancer
• Membre d'associations d'oncologie turques avec des réalisations académiques progressives

Le Dr Gal Goldstein, reconnu sur la liste des meilleurs médecins de Forbes, dirige le Département d'Oncologie et d'Hémato-Oncologie Pédiatrique à l'Hôpital Hadassah Ein Kerem.

• Plus de 20 ans de spécialisation en hémato-oncologie pédiatrique et en transplantation de moelle osseuse haplo-identique
• Membre de plusieurs associations d'oncologie prestigieuses, y compris la SIOP et l'ISPHO
• Se concentre sur le rétinoblastome et la médecine de précision en oncologie pédiatrique

Le Dr Alon Pikarsky apporte plus de 30 ans d'expertise chirurgicale, spécialisé en chirurgie colorectale au Centre Médical Hadassah.

• Instructeur en chirurgie depuis 1995, formant les futurs chirurgiens
• Directeur du programme des étudiants en médecine depuis 1997
• Certifié par le Conseil Israélien en Chirurgie Générale depuis 1998
• Membre de diverses associations chirurgicales depuis 1998

Le Dr Auala Hubert dirige le Centre du cancer gastro-intestinal au Hadassah Medical Center, avec 33 ans d'expérience spécialisée en oncologie et en radiothérapie.

• Spécialisé en Oncologie médicale et radiothérapie
• Médecin senior à l'Hôpital universitaire Hadassah
• Certifié en Oncologie et radiothérapie
• Membre de la Société israélienne d'oncologie clinique

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Le Professeur Myriam Ben Arush est une spécialiste internationalement reconnue en oncologie pédiatrique et en transplantation de moelle osseuse à l'Hôpital pour enfants Ruth Rappaport.

• Directrice de la division pédiatrique au Centre médical Rambam
• Récipiendaire du titre de Chevalier de la Légion d’Honneur en France
• Nommée l'une des médecins les plus attentionnés au monde par l'Association médicale mondiale
• Membre du groupe d'oncologie pédiatrique aux États-Unis et de sociétés européennes de lutte contre le cancer

Spécialisé dans les tumeurs de la tête et du cou et le cancer de la thyroïde, utilisant des techniques de radiothérapie avancées au Centre Médical Hadassah.

• Formation en radiochirurgie au Memorial Sloan Kettering Cancer Center
• Plus de 20 ans d'expérience en oncologie et radiothérapie
• Ancien Chef de la Division d'Oncologie de la Tête et du Cou au Centre de Cancérologie Davidoff
• Directeur du Département d'Oncologie à Hadassah depuis 2019

Le Dr Pfeffer est spécialisé en oncologie et en radiologie à l'Assuta Medical Center, où il propose des traitements de radiothérapie ciblée.

• Double expertise en oncologie et radiologie pour des soins complets
• Exerce à l'Assuta Medical Center – un établissement de premier plan en Israël
• Se concentre sur des plans de radiothérapie personnalisés pour chaque patient

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Le Dr Zalmanova est spécialisée en radiothérapie au Centre Médical Assuta, où elle dispense des traitements ciblés contre le cancer.

• Se concentre sur l'administration d'une radiothérapie précise
• Travaille avec des technologies de radiothérapie de pointe
• Fait partie d'une équipe d'oncologie réputée à Assuta

Dr. Lucía González Cortijo is a medical oncologist with more than 20 years of experience. She has led the Medical Oncology Department at Hospital Universitario Quirónsalud Madrid since 2020. Her focus areas include breast and gynecologic cancers. She also works in precision oncology, targeted therapies, and immunotherapy.

She has been Principal Investigator in more than 20 Phase II–III clinical trials. She has also served as sub-investigator in over 50 international trials. She previously worked at Quirónsalud Madrid from 2009 to 2020. Before that, she was at MD Anderson Cancer Center Madrid from 2002 to 2009.

She holds an MD and a PhD (cum laude) from the Autonomous University of Madrid. She completed her Medical Oncology specialty training at Hospital 12 de Octubre. She also earned a Master’s in Molecular Oncology. She is a member of SEOM, ESMO, ASCO, and GEICAM. She is a university lecturer.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.